Results 201 to 210 of about 16,485 (262)

[Tritium-labeled reactive analogs of [1,6-alpha-aminosuberic acid, 8-arginine] vasopressin (deamino-dicarba-[8-arginine] vasopressin. synthesis and properties].

Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1983
The synthesis of three reactive analogues of [1,6-alpha-aminosuberic acid, 8-arginine]-vasopressin ([Asu1,6,Arg8]vasopressin) is described. Two peptide hormone analogues contain in the p-position of Phe2 the azido or 3-(3-methyl-3-diazirinyl)propanoylamino residue, which can be converted by photoactivation into nitrenes and carbenes, respectively.
F, Fahrenholz, H S, Husseini, J L, Morgat, K H, Thierauch   +3 more
openaire   +1 more source

Effect of 1-deamino-5-D-arginine vasopressin (DDAVP) on plasma cortisol (hydrocortisone).

Journal of clinical pharmacology, 1976
The influence of 1-deamino-8-D-arginine vasopressin (DDAVP), the new antidiutetic polypeptide without any side effects on plasma cortisol, was investigated in 30 healthy persons. A dose of 4 mug DDAVP administered intravenously induced a rise in plasma cortisol (hydrocortisone) levels greater than 3.5 mug/100 ml in 12 out of 20 persons studied. In this
J P, Rado, E, Juhos
openaire   +1 more source

2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists.

Journal of Medicinal Chemistry, 1989
B. Lammek, K. Bańkowski, A. Misicka, M. Manning, J. Seto, W. Sawyer   +5 more
semanticscholar   +1 more source

Response to 1-deamino-8-D-arginine vasopressin in von Willebrand disease.

Haemostasis, 1995
The synthetic agent, 1-deamino-8-D-arginine vasopressin (DDAVP), is generally regarded to be the treatment of choice for persons with type I von Willebrand disease (vWD), and may be useful in type IIA vWD as well. Several formulations of the drug are available, including a highly concentrated intranasal spray formulation which is ideal for home use ...
openaire   +1 more source

The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.

International journal of clinical pharmacology and biopharmacy, 1976
1. After administration of a new vasopressin analogue (DDAVP), a marked and prolonged antidiuresis occurred in 10 patients with pituitary diabetes insipidus. 2. The antidiuretic effects of single intravenous doses of 0.04--24 mug DDAVP and single intranasal doses of 5--320 mug DDAVP were investigated. Time curves of the antidiuretic responses expressed
J P, Radó, J, Marosi, L, Szende, L, Borbély, J, Takó, J, Fischer   +5 more
openaire   +1 more source

1-Deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease.

American journal of hematology, 1985
The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent.
W T, Hanna, J, Slywka, J, Dent, Z M, Ruggeri, T S, Zimmerman   +4 more
openaire   +1 more source

Effect of 1-deamino-8-D-arginine vasopressin on the prolonged bleeding time in chronic renal failure.

Nephron, 1982
A. Watson, J. Keogh
semanticscholar   +1 more source

Absorption of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in rabbits.

Acta Endocrinologica, 1986
S. Lundin, H. Vilhardt
semanticscholar   +1 more source

Impermeability of the blood‐cerebrospinal fluid barrier to 1‐deamino‐8‐D‐arginine‐vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus

European Journal of Clinical Investigation, 1984
PER SOELBERG Sørensen, H. Vilhardt, F. Gjerris, J. Warberg   +3 more
semanticscholar   +1 more source

Oxytocin and vasopressin within the ventral and dorsal lateral septum modulate aggression in female rats

Nature Communications, 2021
Vinícius Elias de Moura Oliveira, Michael Lukas, Hannah Nora Wolf   +2 more
exaly